apyrase has been researched along with Stroke* in 4 studies
1 review(s) available for apyrase and Stroke
Article | Year |
---|---|
CD39: Interface between vascular thrombosis and inflammation.
Extracellular nucleotides play a critical role in vascular thrombosis and inflammation. Alterations in purinergic extracellular nucleotide concentrations activate pathways that result in platelet degranulation and aggregation, and endothelial and leukocyte activation and recruitment. CD39, the dominant vascular nucleotidase, hydrolyzes ATP and ADP to provide the substrate for generation of the anti-inflammatory and antithrombotic mediator adenosine. The purinergic signaling system, with CD39 at its center, plays an important role in modulating vascular homeostasis and the response to vascular injury, as seen in clinically relevant diseases such as stroke, ischemia-reperfusion injury, and pulmonary hypertension. A growing body of knowledge of the purinergic signaling pathway implicates CD39 as a critical modulator of vascular thrombosis and inflammation. Therapeutic strategies targeting CD39 offer promising opportunities in the management of vascular thromboinflammatory diseases. Topics: Antigens, CD; Apyrase; Atherosclerosis; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Inflammation; Myocardial Ischemia; Myocardial Reperfusion Injury; Signal Transduction; Stroke; Thrombosis; Vasculitis | 2014 |
3 other study(ies) available for apyrase and Stroke
Article | Year |
---|---|
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes.
Adenosine modulates many physiological processes through the interaction with adenosine receptors (ARs) named as A Topics: 5'-Nucleotidase; Adenosine; Aged; Aged, 80 and over; Antigens, CD; Apyrase; Brain Ischemia; Female; GPI-Linked Proteins; Humans; Ischemic Stroke; Lymphocytes; Male; Membrane Proteins; Phosphoproteins; Receptors, Purinergic P1; Stroke | 2020 |
Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients.
Regulatory T cells (Tregs) have been suggested to modulate stroke-induced immune responses. However, analyses of Tregs in patients and in experimental stroke have yielded contradictory findings. We performed the current study to assess the regulation and function of Tregs in peripheral blood of stroke patients. Age dependent expression of CD39 on Tregs was quantified in mice and men.. Total FoxP3(+) Tregs and CD39(+)FoxP3(+) Tregs were quantified by flow cytometry in controls and stroke patients on admission and on days 1, 3, 5, and 7 thereafter. Treg function was assessed by quantifying the inhibition of activation-induced expression of CD69 and CD154 on T effector cells (Teffs).. Total Tregs accounted for 5.0% of CD4(+) T cells in controls and <2.8% in stroke patients on admission. They remained below control values until day 7. CD39(+) Tregs were most strongly reduced in stroke patients. On day 3 the Treg-mediated inhibition of CD154 upregulation on CD4(+) Teff was impaired in stroke patients. CD39 expression on Treg increased with age in peripheral blood of mice and men.. We demonstrate a loss of active FoxP3(+)CD39(+) Tregs from stroke patient's peripheral blood. The suppressive Treg function of remaining Tregs is impaired after stroke. Topics: Aged; Aged, 80 and over; Animals; Antigens, CD; Apyrase; CD4-Positive T-Lymphocytes; Female; Forkhead Transcription Factors; Humans; Male; Mice; Middle Aged; Stroke; T-Lymphocytes, Regulatory | 2016 |
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.
Endothelial CD39 metabolizes ADP released from activated platelets. Recombinant soluble human CD39 (solCD39) potently inhibited ex vivo platelet aggregation in response to ADP and reduced cerebral infarct volumes in mice following transient middle cerebral artery occlusion, even when given 3 hours after stroke. Postischemic platelet and fibrin deposition were decreased and perfusion increased without increasing intracerebral hemorrhage. In contrast, aspirin did not increase postischemic blood flow or reduce infarction volume, but did increase intracerebral hemorrhage. Mice lacking the enzymatically active extracellular portion of the CD39 molecule were generated by replacement of exons 4-6 (apyrase-conserved regions 2-4) with a PGKneo cassette. Although CD39 mRNA 3' of the neomycin cassette insertion site was detected, brains from these mice lacked both apyrase activity and CD39 immunoreactivity. Although their baseline phenotype, hematological profiles, and bleeding times were normal, cd39(-/-) mice exhibited increased cerebral infarct volumes and reduced postischemic perfusion. solCD39 reconstituted these mice, restoring postischemic cerebral perfusion and rescuing them from cerebral injury. These data demonstrate that CD39 exerts a protective thromboregulatory function in stroke. Topics: Adenosine Triphosphatases; Animals; Antigens, CD; Apyrase; Aspirin; Brain Ischemia; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Stroke; Thrombosis | 2002 |